ES2006474A6 - Procedimiento para preparar composiciones farmaceuticas que contienen acido nordihidroguayaretico y halogenuro de metal no alcalino. - Google Patents

Procedimiento para preparar composiciones farmaceuticas que contienen acido nordihidroguayaretico y halogenuro de metal no alcalino.

Info

Publication number
ES2006474A6
ES2006474A6 ES8701366A ES8701366A ES2006474A6 ES 2006474 A6 ES2006474 A6 ES 2006474A6 ES 8701366 A ES8701366 A ES 8701366A ES 8701366 A ES8701366 A ES 8701366A ES 2006474 A6 ES2006474 A6 ES 2006474A6
Authority
ES
Spain
Prior art keywords
zygophyllaceae
modification
plant extracts
osteomyelitis
warts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8701366A
Other languages
English (en)
Inventor
Russell T Jordan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of ES2006474A6 publication Critical patent/ES2006474A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ACIDO NORDIHIDROGUAYARETICO Y HALOGENURO DE METAL NO ALCALINO, EN EL QUE SE HABILITA UNA COMPOSICION QUE COMPRENDE ACIDO NORDIHIDROGUAYARETICO, CONSTITUIDA PREFERIBLEMENTE POR UN EXTRACTO DE PLANTAS DE LA FAMILIA DE LAS ZIGOFILACEAS, SE MEZCLA LA COMPOSICION CON UNA SOLUCION ACUOSA DE UNA SAL DE METAL ALCALINO, SE SECA LA MEZCLA DURANTE UN PERIODO DE TIEMPO SUFICIENTE PARA LOGRAR EL GRADO DE SECADO DESEADO, SE SUSPENDE EN AGUA LA MEZCLA SECADA Y SE VUELVE A SECAR ESTA ULTIMA. LAS COMPOSICIONES OBTENIDAS SON APLICABLES AL TRATAMIENTO DEL CANCER, TUMORES NO MALIGNOS, OSTEOMIELITIS, PSORIASIS Y VERRUGAS.
ES8701366A 1986-05-07 1987-05-07 Procedimiento para preparar composiciones farmaceuticas que contienen acido nordihidroguayaretico y halogenuro de metal no alcalino. Expired ES2006474A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/860,654 US4774229A (en) 1982-04-05 1986-05-07 Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor

Publications (1)

Publication Number Publication Date
ES2006474A6 true ES2006474A6 (es) 1989-05-01

Family

ID=25333707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8701366A Expired ES2006474A6 (es) 1986-05-07 1987-05-07 Procedimiento para preparar composiciones farmaceuticas que contienen acido nordihidroguayaretico y halogenuro de metal no alcalino.

Country Status (5)

Country Link
US (1) US4774229A (es)
AU (1) AU6729887A (es)
CA (1) CA1303497C (es)
ES (1) ES2006474A6 (es)
WO (1) WO1987006833A1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051233A1 (es) * 1992-11-16 1994-06-01 Inkeysa Sa Composiciones terapeuticas de uso topico para el tratamiento efectivo de la psoriasis.
ES2065292A1 (es) * 1993-07-30 1995-02-01 Inkeysa Sa Composiciones terapeuticas de uso topico para el tratamiento de la psoriaris.

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880637A (en) * 1985-02-11 1989-11-14 Chemex Pharmaceuticals, Inc. Compositions of catecholic butanes with zinc
DK0387042T3 (da) * 1989-03-08 1995-04-03 Hayashibara Biochem Lab Fremstilling og anvendelser af alpha-glycosyl-rutin
FR2660861B1 (fr) * 1990-04-12 1994-11-04 Claude Bonne Compositions cosmetiques contenant un extrait d'une zygophyllacee appartenant au genre larrea.
US5478579A (en) * 1991-02-06 1995-12-26 Biodyn Medical Research, Inc. Method for treatment of osteoporosis
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
CN1047525C (zh) * 1993-03-13 1999-12-22 刘同乐 治疗癌症的药物
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
GB2291347A (en) 1994-06-24 1996-01-24 Phytopharm Ltd Pharmaceutical compositions comprising extracts of Chinese herbs
US6365787B1 (en) 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
US5989555A (en) * 1996-05-02 1999-11-23 Gnabre; John N. Extracts of Larrea tridentata having antiviral activity and their use for treating viral infections
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US6323168B1 (en) * 1996-07-03 2001-11-27 Advanced Technology Materials, Inc. Post plasma ashing wafer cleaning formulation
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
US5776463A (en) * 1997-02-19 1998-07-07 Arginteanu; Ronit Method of reducing stress and circulatory heart disease with freeze-dried borage petal extracts
US5804206A (en) * 1997-03-06 1998-09-08 Bio-Botanica, Inc. Therapeutic composition and method for treating skin using Centipeda cunninghami extract
WO1999017609A1 (en) * 1997-10-07 1999-04-15 Larreacorp, Ltd. Nontoxic extract of larrea tridentata and method of making the same
US6024960A (en) * 1998-04-17 2000-02-15 Otto Torbjorn Hansen And Marianne Hansen Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
GR1003283B (el) * 1998-06-05 1999-12-10 6ft � @s�u5 0t55 f@ sf@u 5095 #0@*0#s*#0@*0 0t5@t @6* 9 tt 5 @M]@st0@ 0 #@ 5@st @F#
US6987125B1 (en) * 1998-10-06 2006-01-17 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
AU2998900A (en) * 1999-02-19 2000-09-04 Leslee S. Brooks Zinc chloride in treating skin diseases
US6343258B1 (en) 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
US6608108B2 (en) 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
KR100408231B1 (ko) * 2000-08-14 2003-12-01 한국 한의학 연구원 골다공증 예방 및 치료용 플라보노이드 유도체
US6485752B1 (en) 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
AUPR726701A0 (en) * 2001-08-24 2001-09-20 HWF Enterprises Pty Ltd Compound for treatment of lesions and tumours
KR100388787B1 (en) * 2002-06-28 2003-06-25 Lifetree Biotech Co Ltd Composition for prevention and treatment of liver cancer, containing phenolic compound
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US7728036B2 (en) 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
JP2007500229A (ja) * 2003-05-20 2007-01-11 ジョンズ・ホプキンズ・ユニバーシティ 腫瘍の治療のためのカテコールブタンの投与のための方法と組成物
US20050123560A1 (en) * 2003-12-04 2005-06-09 Sinnott Robert A. High purity and water dispersible extract and formulations of larrea tridentata leaf resin, and methods of making and using the same
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
BRPI0513447A (pt) * 2004-07-28 2008-06-10 Abbott Lab composições nutritivas e métodos para o tratamento ou prevenção de osteoporose
US20080096967A1 (en) * 2005-01-27 2008-04-24 Erimos Pharmaceuticals Llc Formulations for Injection of Catecholic Butanes, Including Ndga Compounds, Into Animals
CN101340922B (zh) * 2005-12-20 2011-05-11 阿布杜勒阿齐兹·默罕默德·阿尔—叶海亚 蒺藜冻干提取物用作抗变态反应治疗
WO2007101111A2 (en) * 2006-02-23 2007-09-07 Erimos Pharmaceuticals Llc Methods of treating influenza viral infections
EP1832294A1 (de) * 2006-03-09 2007-09-12 Gundula Geske Verwendung von Guajakholz zur Behandlung von Entzündungen der Haut
US7914827B2 (en) 2006-07-05 2011-03-29 Max Zeller Soehne Ag Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same
US8178527B2 (en) * 2006-10-02 2012-05-15 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
EP2119434A1 (en) * 2008-05-13 2009-11-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of heterosidic flavonoid derivatives for therapy of stem cell cancers
WO2011156311A2 (en) * 2010-06-07 2011-12-15 L'oreal Cosmetic compositions containing phenolic compounds
US10532040B2 (en) 2011-11-18 2020-01-14 Regents Of The University Of Minnesota Methods of treating cancer with herbacetin
CN103239438B (zh) * 2013-05-20 2014-08-06 昆明理工大学 熊竹素在制备抑制血管异常新生药物中的应用
KR101580716B1 (ko) * 2013-05-29 2015-12-30 숙명여자대학교산학협력단 라리아 니티다 추출물로부터 분리한 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는, 여성암과 갱년기 증상의 예방 및 치료용 약학적 조성물
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
MX2018002189A (es) * 2018-02-21 2019-08-22 Juan Genaro Osuna Sanchez Extracto funcionalizado de larrea tridentata con actividad biocida.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU162759B (es) * 1971-01-18 1973-04-28
US4153788A (en) * 1974-04-09 1979-05-08 Zyma S.A. Process of preparing mono-O-β-hydroxyethyl-7 rutoside
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4229437A (en) * 1978-07-18 1980-10-21 Lucille Likens Filson Paste or dough-like salve for treating skin
JPS58225083A (ja) * 1982-06-23 1983-12-27 Nippon Shinyaku Co Ltd メチルフラボン誘導体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051233A1 (es) * 1992-11-16 1994-06-01 Inkeysa Sa Composiciones terapeuticas de uso topico para el tratamiento efectivo de la psoriasis.
ES2065292A1 (es) * 1993-07-30 1995-02-01 Inkeysa Sa Composiciones terapeuticas de uso topico para el tratamiento de la psoriaris.

Also Published As

Publication number Publication date
US4774229A (en) 1988-09-27
AU6729887A (en) 1987-12-01
CA1303497C (en) 1992-06-16
WO1987006833A1 (en) 1987-11-19

Similar Documents

Publication Publication Date Title
ES2006474A6 (es) Procedimiento para preparar composiciones farmaceuticas que contienen acido nordihidroguayaretico y halogenuro de metal no alcalino.
GEP19971015B (en) Novel compositions containing hyaluronic acid associates and a process for preparing same
UA34419C2 (uk) Ліофілізований препарат для ін'єкцій та спосіб інгібування росту пухлин
IE802744L (en) Platinum (iv)-diamine complexes
PL308770A1 (en) Oak bark extract compositions, similar synthetic composition and method of obtaining them
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
DE3370482D1 (en) Substituted 8-phenylxanthines
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
EP0175468A3 (en) Eicosanoids for use in cancer therapy
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
PL313223A1 (en) Nigella sativa as a therapeutic agent
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
ES8505171A1 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno y de indano.
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
IE44431L (en) Pyrimid-2-ones
ES466940A1 (es) Procedimiento para la obtencion de derivados de 6-etoxi-1,2 -dihidro-2,2,4-trimetilquinolina.
ES8101891A1 (es) Procedimiento para la preparacion de un preparado de secre- tina con efecto reforzado y retardado
EG20140A (en) A process for preparing of pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
DE3373099D1 (en) Extract of plants of the family of hypoxidaceae for treatment of cancer
DE3163920D1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
AU645808B2 (en) Comestic compositions containing a zygophyllaceae extract belonging to the genus larrea
ES8300780A1 (es) Procedimiento para preparar oxido de bis(cloroetil-butilestano)
GB2074865A (en) Cosmetic preparation
EP0129822A3 (de) Neue pharmazeutische Zubereitungen mit Antitumorwirkung

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401